Aleafia Health Inc

Aleafia Health — Investor Presentation (October 2021)

27 slides from Aleafia Health's investor presentation, October 2021

  1. Slide 1: Corporate Presentation October 2021

    TSX: AH OTCQX: ALEAF Corporate Presentation October 2021 AleafiaHealth.com

  2. Slide 2: Forward-looking statements

    Certain statements herein relating to the Company constitute “forward looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions,

  3. Slide 3: Q2 2021 Highlights

    Q2 2021 HIGHLIGHTS 53% Increase in total 87 % Increase in adult-use 23 % Increase in medical 66 % Increase in bulk cannabis cannabis net revenue cannabis wholesale cannabis net net revenue Q/Q Q/Q net revenue Q/Q revenue Q/Q 49 % 1 st 3 $17.8 Adjusted gross margin Medical cannabis New employers Cash

  4. Slide 4: Company Snapshot

    COMPANY SNAPSHOT 40 New SKUs launched since Q4 2020 PRODUCT PORTFOLIO 5 Cannabis brands targeting consumer segments 75,000+ Unique clinic patients seen ~$40 million LQ Run-rate cannabis net revenue FINANCIALS ~49% (1) Industry leading adjusted gross profit margins 171% Y/Y increase in cannabis reven

  5. Slide 5: Investment Highlights

    INVESTMENT HIGHLIGHTS VERTICAL INTEGRATION STRONG FINANCIAL PERFORMANCE • Cultivation, extraction capacity, packaging across 3 facilities • 53% sequential net cannabis revenue growth • Distribution capabilities nationally for medical products, and • Diversified sales mix with three sales channels: m

  6. Slide 6: Integrated Across Full Cannabis Value Chain

    INTEGRATED ACROSS FULL CANNABIS VALUE CHAIN CULTIVATION SUPPLY CHAIN & CLINICS & EXTRACTION MANUFACTURING BRAND PORTFOLIO DISTRIBUTION RESEARCH 1 2 3 4 5 6 Diversified, low- Converting flower to Same day delivery National patient Growing consumer cannabis derivatives Product innovation acquisition m

  7. Slide 7: Diversified, Low-Cost Cultivation

    DIVERSIFIED, LOW-COST CULTIVATION LOW-COST CULTIVATION ADVANTAGE Port Perry, Ont.  First large scale legal outdoor grow in Canada  86 Acres planted in 2021  32,000 kgs outdoor harvest yield in 2020 AUTOMATED GREENHOUSE Grimsby, Ont.  EU-GACP compliant for EU exports  2,000 kgs monthly harvest r

  8. Slide 8: Brand Portfolio Targeting Key Consumer Segments

    BRAND PORTFOLIO TARGETING KEY CONSUMER SEGMENTS MEDICAL SUBLINGUALS PREMIUM EDIBLES VALUE WELLNESS • Medical cannabis • Broad appeal. • Premium, flagship • Consumers and • High frequency • Daily health & wellness patients. • Cannabis consumers brand. patients. consumers, large brand. • Oils, dried f

  9. Slide 9: Growth & Margin Leadership – Four Key Channels

    GROWTH & MARGIN LEADERSHIP – FOUR KEY CHANNELS MEDICAL ADULT-USE WHOLESALE INTERNATIONAL Q/Q REVENUE GROWTH1 11 % 87 % 66 % 215 % ADJUSTED GROSS MARGIN 44 % 47 % 60 % 25 % 1. Q2/21 vs Q1/21. STRONG UNIQUE DIFFERENTIATED MULTI- VERTICAL DIVERSIFIED FINANCIAL MEDICAL PRODUCT CHANNEL INTEGRATION PRODUC

  10. Slide 10: Medical Channel Overview

    MEDICAL CHANNEL OVERVIEW Overview of Business Growing Active Patient Base  LQ Run-Rate Net Revenue $12.9 million  23% increase in medical cannabis 18,067 net revenue Q/Q (domestic & Intl.)  “Sticky”, recurring revenue model  Stable active patient base (~18,000) 13,285  Strong ordering patterns

  11. Slide 11: Unique Medical Patient Ecosystem

    UNIQUE MEDICAL PATIENT ECOSYSTEM Medical Ecosystem Same Day Delivery Platform Diverse product 9AM portfolio VIRTUAL CONSULTATION Virtual Same day delivery in the consultations Until across GTA Canada 2PM ORDER FULFILLED Exclusive agreement w/ Canada’s largest union 1. Based on May to July 2021. SAME

  12. Slide 12: Unifor Partnership Provides Pathway to High-Margin Recurring Revenue

    UNIFOR PARTNERSHIP PROVIDES PATHWAY HIGH-MARGIN RECURRING REVENUE TAM $300+ Million 1 Partnership Highlights  10-year exclusive partnership  315,000 members (+ family & retirees)  Unionized employers span multiple industries, including automotive, telecommunications, air/rail transportation, serv

  13. Slide 13: Strong Growth in the Medical Channel

    STRONG GROWTH IN THE MEDICAL CHANNEL Net Revenue (m) 1 Growth Catalysts GROWING ACTIVE PATIENT BASE 23% Quarter over quarter growth in medical cannabis net revenue $4.4  Onboarded 3 employers through 10-year Unifor agreement for insurance backed medical cannabis care $3.8  Initiated growth strateg

  14. Slide 14: Adult-Use Channel Overview

    ADULT-USE CHANNEL OVERVIEW Overview of Business Q2 Highlights  Sunday Market House of Brands launched Divvy a top searched brand on #3 OCS.com in Q1 2021  5 brands targeting specific consumer segment Entered top 10 in Ontario for PRE-ROLLS pre-roll market in Q3 to date  Divvy, the everyday value

  15. Slide 15: Brand & Market Share Momentum

    BRAND & MARKET SHARE MOMENTUM Brand Awareness Accelerating Brand Traction Continues to Build Divvy was the #3 most searched brand on  Market share rank has jumped 15 spots in OCS May 2021 the last six months (Licensed Producer Rankings, Hifyre)  Creation of the Sunday Market house of brands to con

  16. Slide 16: Strong Growth & Consumer Demand

    STRONG GROWTH & CONSUMER DEMAND Adult-Use Net Revenue Growth Catalysts 87% Quarter over quarter growth $3.2 CAPTURE MARKET SHARE in adult-use cannabis net revenue  Direct sales team driving market share gains  Focused on the largest product categories, flower, pre-roll and vapes IMPROVED RETAIL PE

  17. Slide 17: Consistent Revenue Growth & Industry Leading Margins

    CONSISTENT REVENUE GROWTH & INDUSTRY LEADING MARGINS Net Revenue Gross Profit & Margin Profile Gross Profit Gross Profit Margin $44.5 $23.5 53% 49% 46% $16.4 $7.6 $3.3 $1.6 2018 2019 2020 2018 2019 2020 STRONG UNIQUE DIFFERENTIATED MULTI- VERTICAL DIVERSIFIED FINANCIAL MEDICAL PRODUCT CHANNEL INTEGR

  18. Slide 18: Diversified, Sustainable Sales Mix

    DIVERSIFIED, SUSTAINABLE SALES MIX Q2 2020 Cannabis Net Revenue by Sales Channel Q2 2021 Cannabis Net Revenue by Sales Channel Over the last four quarters, strong growth in adult-use 10% and medical has resulted in a highly diversified sales mix. 32% 34% 22% 68% 34% Adult-Use Medical Bulk-Wholesale

  19. Slide 19: Driving Operating Leverage on Pathway Towards Profitability

    DRIVING OPERATING LEVERAGE ON PATHWAY TOWARDS PROFITABILITY Total Revenue / SG&A Improving Operating Leverage  As revenue scales, Aleafia benefits from operating 1.8x leverage in SG&A expenditures  Utilize temp / hourly labour to address seasonal needs in growing operations  Corporate shared serv

  20. Slide 20: Building Sustainable Profitability

    BUILDING SUSTAINABLE PROFITABLY Adjusted EBITDA (m) Initiatives to Drive Profitability $9.0  Flexibility to place cultivation product into sales channel with highest net realizable margin potential  Low-cost outdoor grow broadens sales opportunities with attractive margin profiles  Focused on cos

  21. Slide 21: Management

    MANAGEMENT MATT SALE GREG ROSSI Chief Financial Officer Chief Operating Officer 15 years experience in senior leadership roles w/ Executive consultant on supply chain logistics at BMO Capital Markets and Raym ond Jam es’ Walm art, Cam pbell, Kraft Heinz, Nestle, Mondelez. investm ent banking groups.

  22. Slide 22: Appendix

    APPENDIX 22

  23. Slide 23: Summary Financials & Capitalization Table

    SUMMARY FINANCIALS & CAPITALIZATION TABLE CAD $'000s Three months ended % Change ($,000s, except operational results) Q2 2021 Q1 2021 Q2 2020 Q/Q Y/Y Share price1 (actual dollars) $0.41 Cannabis net revenue(1)(2) 9,583 6,245 8,995 53% 7% Common shares outstanding (000's) 330,723 Net medical cannabis

  24. Slide 24: 35,000 sq. ft. Product Innovation Centre

    35,000 sq. ft. Product Innovation Centre Features Flower Packaging Extraction Lab Licence date May 2020 EU-GMP Purpose built to EU-GMP specs, Vape Cartridges Sublingual Strips application in process For production of cannabis edible Commercial kitchen products Vape cartridges Launched Oct 2020 Subli

  25. Slide 25: 160,000 sq. ft. Greenhouse Cultivation

    160,000 sq. ft. Greenhouse Cultivation Features Licence date March 2020 Automated production throughout State of the art plant lifecycle Modern design w/ moving Dutch hybrid container bench system Daily harvests all year to maximize Perpetual harvest supply chain efficiency 7 individual climate cont

  26. Slide 26: 86 Acres Outdoor Cultivation

    86 Acres Outdoor Cultivation Features June 2019 (26 acres), May 2020 Licence date (60 acre expansion) Low-cost at scale $0.10 cost per gram Extractable biomass for derivative Product input products 7,120 kgs of high-THC flower Adult-use flower harvested (2020) 2019 harvest 13,000 kgs dried flower 20

  27. Slide 27: Shareholder Information / Investor Contacts

    SHAREHOLDER INFORMATION INVESTOR CONTACTS Ticker Symbol: t / 1 -833-879-2533 TSX / AH e / IR@AleafiaHealt h.com Registrar and Transfer Agent Nicholas Bergamini Com put ershare Ltd. Vancouver VP, Investor Relat ions & 510 Burrard St, 3rd Floor Com m unicat ions Vancouver, BC V6C 3B9 t / 1-80 0 -564 -

Aleafia Health — Investor Presentation (October 2021) on 6ix